VerifiedBiotechnology Research· Founded 2021

Nanocarry Therapeutics

Nanocarry is developing a new class of therapeutics based on bioengineered nanoparticles with novel capabilities to treat oncology indications and brain diseases. Using a proprietary “Plug and Play” approach, Nanocarry’s AxS platform can be easily modified to deliver a wide array of biologics, safely and effectively, to the brain and beyond. Nanocarry’s first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer.

7-day free trial · no credit card

Israel12(1 to 10)2021nanocarry.com LinkedIn

Verified contacts

12

available on Kipplo

LinkedIn employees

12

1 to 10 range

Open roles

—

no listings

Distinct roles

11

indexed titles

Tech stack

0

tools in use

Monthly traffic

—

organic / mo

Sign up free to see all 12 verified contacts at Nanocarry Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

12 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 6 of 12 verified contacts

Top roles at Nanocarry Therapeutics

11 distinct titles indexed · top 10 shown.

1board member
1ceo & founder
1chief business officer
1cmc director
1communications and business development associate
1director of operations
1founder & coo
1research assistant
1scientist
1senior scientist
+1more titles

Sign up to unlock all 12 contacts at Nanocarry Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 12 verified contacts at Nanocarry Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Nanocarry Therapeutics | Kipplo Discover